CLINICAL_TRIALS
trial_result
· 2025-11-12
Clinical Trial Update: PS230005 Control-IQ 1.5 Post-Approval Study
Summary
Post-approval clinical trial update for the Control-IQ 1.5 system in Type 1 diabetes; the PS230005 study is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tandem Diabetes Care, Inc. | Conditions: Type 1 Diabetes | Status: ACTIVE_NOT_RECRUITING